Table 6.
online only. Barriers to Blood Pressure and/or Lipid Management
Patient barriers | Never/Rarely | Sometimes | Often/Always |
---|---|---|---|
Do not have sufficient support for successful lifestyle changes | 3% | 28% | 69% |
Are not motivated to control blood pressure and/or lipid levels | 4% | 34% | 62% |
Are not confident that they can follow-through with lifestyle changes | 3% | 35% | 61% |
Are resistant to start a medication that may be life-long | 13% | 43% | 44% |
Do not understand that untreated blood pressure or elevated lipid levels may increase risk of diabetes complications | 16% | 41% | 43% |
Are focused on diabetes management and cannot add another condition | 14% | 49% | 37% |
Do not believe blood pressure and/or lipid medications are important in youth with diabetes | 34% | 38% | 28% |
Medical barriers | |||
Insufficient patient education materials on hypertension and/or hyperlipidemia for these youth | 21% | 40% | 40% |
Visits too short to focus on diabetes AND hypertension and/or hyperlipidemia | 19% | 42% | 39% |
Limited provider training on hypertension and/or hyperlipidemia management in youth with type 1 diabetes | 34% | 33% | 33% |
Insufficient evidence for hypertension and/or lipid management in youth | 51% | 31% | 18% |
Practice systems make it difficult to recognize when BP or lipid levels need intervention | 53% | 32% | 14% |
Lack of familiarity with practice guidelines | 56% | 31% | 13% |
Do not want to distract from blood glucose management | 56% | 33% | 11% |
Lack of local subspecialists for referral for hypertension and/or lipid management appropriate for youth with type 1 diabetes | 71% | 20% | 9% |
Discomfort discussing complication risk with concurrent diabetes and hypertension and/or hyperlipidemia | 73% | 20% | 7% |
Prescription barriers | |||
Concerns about pregnancy (in females) | 26% | 39% | 35% |
Concerns about patient adherence | 24% | 44% | 32% |
Lack of expertise in this area | 39% | 39% | 23% |
Hesitancy to start a medication that may be life-long | 47% | 33% | 21% |
Limited evidence in youth with type 1 diabetes | 39% | 43% | 18% |